Table 1

Overview of antimicrobial therapy at the index visit according to the microscopy result of the urine sample

Community resistance level in 2009 (E.coli only)

no organism, no pyuria

Pyuria

organism

Total

Co-amoxyclav

30.5%

N

87

21

51

159

% of total

18.1%

4.4%

10.6%

33.1%

% within

54.7%

13.2%

32.1%

Ampicillin

68.1%

N

18

1

8

27

% of total

3.7%

0.2%

1.7%

5.6%

% within

66.6%

3.7%

29.6%

Trimethoprim

30.5%

N

60

15

50

125

% of total

12.5%

3.1%

10.4%

26.0%

% within

48.0%

12.0%

40.0%

Fluoroquinolone

8.3%

N

54

8

20

82

% of total

11.2%

1.7%

4.2%

17.0%

% within

65.9%

9.8%

24.4%

Nitrofurantoin

4.1%

N

29

6

22

57

% of total

6.0%

1.2%

4.6%

11.9%

% within

50.9%

10.5%

38.6%

Other

N

20

4

7

31

% of total

4.2%

0.8%

1.5%

6.4%

% within

64.5%

12.9%

22.6%

Total

N

268

55

158

481

% of total

55.7%

11.4%

32.8%

100.0%

The number (N) and percentage (% within) of each antimicrobial prescribed is given for patients with no organism or pyuria was identified in the urine sample, when only pyuria was detected and when an organism was detected. The overall percentage of each antimicrobial prescribed (% of total) is also shown. For reference, the community antimicrobial resistance levels of all E.coli from urinary samples (no duplicates) analysed in the laboratory of the Galway University Hospitals during 2009 is presented in the first column.

Vellinga et al. BMC Family Practice 2011 12:108   doi:10.1186/1471-2296-12-108